PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31919718-3	2020	P21-activated kinase 1 (PAK1), a member of serine/threonine kinases, is associated with the progression of multiple types of human cancers.	cholecystokinin C-terminal flanking peptide	43-49	p21 (RAC1) activated kinase 1	Homo sapiens	0-22	
31919718-3	2020	P21-activated kinase 1 (PAK1), a member of serine/threonine kinases, is associated with the progression of multiple types of human cancers.	cholecystokinin C-terminal flanking peptide	43-49	p21 (RAC1) activated kinase 1	Homo sapiens	24-28	
31932503-4	2020	Here, we report that Arl4A acts with the serine/threonine protein kinase Pak1 to modulate cell migration through their cooperative recruitment to the plasma membrane.	cholecystokinin C-terminal flanking peptide	41-47	p21 (RAC1) activated kinase 1	Homo sapiens	73-77	
31614827-0	2019	Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells.	cholecystokinin C-terminal flanking peptide	63-69	p21 (RAC1) activated kinase 1	Homo sapiens	56-60	
31614827-6	2019	In this study, we aimed to determine if simultaneous inhibition of BCR-ABL1 oncogenic tyrosine kinase and PAK1/2 serine/threonine kinase exert better anti-CML effect than that of individual treatments.	cholecystokinin C-terminal flanking peptide	113-119	p21 (RAC1) activated kinase 1	Homo sapiens	106-112